Journal of Animal Reproduction and Biotechnology (한국동물생명공학회지)

The Korean Society of Animal Reproduction and Biotechnology (한국동물생명공학회)
권호 표지
DOI QR코드

DOI QR Code

A rare ginsenoside compound K (CK) induces apoptosis for breast cancer cells

  • Received : 2023.09.11
  • Accepted : 2023.09.18
  • Published : 2023.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: A breast cancer is the second leading cause of cancer death in women worldwide and among different types of breast cancers, triple-negative breast cancer (TNBC) has a poor prognosis. Methods: We investigated the potential of ginsenoside compound K (CK), an active ingredient in the bio-transformed ginsenoside, to be used as a therapeutic ingredient by examining the effects of CK on cell proliferation, apoptosis, and cancer-related gene expressions in breast cancer cells. Results: From the results of treating MCF-7, an ER and PR-positive breast cancer cells, and MDA-MB-231 (TNBC) with CK at a concentration of 0-100 µM, the half maximal inhibitory concentration (IC50) values for each cell were 52.17 µM and 29.88 µM, respectively. And also, it was confirmed that cell migration was inhibited above the IC50 concentration. In addition, fluorescence analysis of Apoptosis/Necrosis showed that CK induced apoptosis rather than necrosis of breast cancer cells. Through qPCR, it was confirmed that the expression of genes related to apoptosis and cell cycle arrest was increased in CK-treated breast cancer cells, and it acted more effectively on TNBC. However, the expression of genes related to tumor invasion and metastasis is also increased, so it is necessary to consider the timing of application of CK as a potential therapeutic anticancer compound. Conclusions: CK showed a stronger inhibitory effect in TNBC with poor prognosis but considering the high tumor invasion and metastasis-related gene expression, the timing of application of CK should be considered.

Keywords

Acknowledgement

This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET) through High Value-added Food Technology Development Program, funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA) (321038-5).

References

  1. American Cancer Society. 2022. About breast cancer. Cancer. org. Retrieved October 7, 2022, from https://www.cancer.org/content/dam/CRC/PDF/Public/8577.00.pdf
  2. Chen HF, Wu LX, Li XF, Zhu YC, Wang WX, Xu CW, Huang ZZ, Du KQ. 2019. Ginsenoside compound K inhibits growth of lung cancer cells via HIF-1α-mediated glucose metabolism. Cell. Mol. Biol. (Noisy-le-grand) 65:48-52. https://doi.org/10.14715/cmb/2019.65.4.8
  3. Chen Y, Xu Y, Zhu Y, Li X. 2013. Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells. Cancer Cell Int. 13:24.
  4. Chiang GG and Abraham RT. 2007. Targeting the mTOR signaling network in cancer. Trends Mol. Med. 13:433-442. https://doi.org/10.1016/j.molmed.2007.08.001
  5. Choi E, Kim E, Kim JH, Yoon K, Kim S, Lee J, Cho JY. 2019. AKT1-targeted proapoptotic activity of compound K in human breast cancer cells. J. Ginseng Res. 43:692-698. https://doi.org/10.1016/j.jgr.2019.07.001
  6. Collignon J, Lousberg L, Schroeder H, Jerusalem G. 2016. Triple-negative breast cancer: treatment challenges and solutions. Breast Cancer (Dove Med. Press) 8:93-107.
  7. DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, Siegel RL. 2019. Breast cancer statistics, 2019. CA Cancer J. Clin. 69:438-451. https://doi.org/10.3322/caac.21583
  8. Fukami H, Ueda T, Matsuoka N. 2019. Pharmacokinetic study of compound K in Japanese subjects after ingestion of Panax ginseng fermented by Lactobacillus paracasei A221 reveals significant increase of absorption into blood. J. Med. Food 22:257-263. https://doi.org/10.1089/jmf.2018.4271
  9. Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D'Angiolella V, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, Di Daniele N, Di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia GM, Fulda S, Garcia-Saez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, Jaattela M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, Lopez-Otin C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Munoz-Pinedo C, Nagata S, Nunez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, Vanden Berghe T, Vandenabeele P, Vander Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G. 2018. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 25:486-541. https://doi.org/10.1038/s41418-017-0012-4
  10. Gartel AL, Serfas MS, Tyner AL. 1996. p21--negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med. 213:138-149. https://doi.org/10.3181/00379727-213-44046
  11. Gartel AL and Tyner AL. 1998. The growth-regulatory role of p21 (WAF1/CIP1). Prog. Mol. Subcell. Biol. 20:43-71. https://doi.org/10.1007/978-3-642-72149-6_4
  12. Hanemaaijer R, Verheijen JH, Maguire TM, Visser H, Toet K, McDermott E, O'Higgins N, Duffy MJ. 2000. Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors. Int. J. Cancer 86:204-207. https://doi.org/10.1002/(SICI)1097-0215(20000415)86:2<204::AID-IJC9>3.0.CO;2-6
  13. Hare SH and Harvey AJ. 2017. mTOR function and therapeutic targeting in breast cancer. Am. J. Cancer Res. 7:383-404.
  14. Hua VY, Wang WK, Duesberg PH. 1997. Dominant transformation by mutated human ras genes in vitro requires more than 100 times higher expression than is observed in cancers. Proc. Natl. Acad. Sci. U. S. A. 94:9614-9619. https://doi.org/10.1073/pnas.94.18.9614
  15. Hu C, Song G, Zhang B, Liu Z, Chen R, Zhang H, Hu T. 2012. Intestinal metabolite compound K of panaxoside inhibits the growth of gastric carcinoma by augmenting apoptosis via Bid-mediated mitochondrial pathway. J. Cell. Mol. Med. 16:96-106. https://doi.org/10.1111/j.1582-4934.2011.01278.x
  16. Jassim MMA, Rasool KH, Mahmood MM. 2021. p53, p21, and cyclin d1 protein expression patterns in patients with breast cancer. Vet. World 14:2833-2838. https://doi.org/10.14202/vetworld.2021.2833-2838
  17. Jin S, Jeon JH, Lee S, Kang WY, Seong SJ, Yoon YR, Choi MK, Song IS. 2019. Detection of 13 ginsenosides (Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg3, Rh2, F1, compound K, 20(S)- protopanaxadiol, and 20(S)-protopanaxatriol) in human plasma and application of the analytical method to human pharmacokinetic studies following two week-repeated administration of red ginseng extract. Molecules 24:2618.
  18. Kwak CW, Son YM, Gu MJ, Kim G, Lee IK, Kye YC, Kim HW, Song KD, Chu H, Park BC, Lee HK, Yang DC, Sprent J, Yun CH. 2015. A bacterial metabolite, compound K, induces programmed necrosis in MCF-7 cells via GSK3β. J. Microbiol. Biotechnol. 25:1170-1176. https://doi.org/10.4014/jmb.1505.05057
  19. Law CK, Kwok HH, Poon PY, Lau CC, Jiang ZH, Tai WC, Hsiao WW, Mak NK, Yue PY, Wong RN. 2014. Ginsenoside compound K induces apoptosis in nasopharyngeal carcinoma cells via activation of apoptosis-inducing factor. Chin. Med. 9:11.
  20. Lee S, Kwon MC, Jang JP, Sohng JK, Jung HJ. 2017. The ginsenoside metabolite compound K inhibits growth, migration and stemness of glioblastoma cells. Int. J. Oncol. 51:414-424. https://doi.org/10.3892/ijo.2017.4054
  21. Li C, Dong Y, Wang L, Xu G, Yang Q, Tang X, Qiao Y, Cong Z. 2019a. Ginsenoside metabolite compound K induces apoptosis and autophagy in non-small cell lung cancer cells via AMPK-mTOR and JNK pathways. Biochem. Cell Biol. 97:406-414. https://doi.org/10.1139/bcb-2018-0226
  22. Li D, Wu Y, Zhang C, Sun J, Zhou Z, Lu W. 2019b. Production of triterpene ginsenoside compound K in the non-conventional yeast Yarrowia lipolytica. J. Agric. Food Chem. 67:2581-2588. https://doi.org/10.1021/acs.jafc.9b00009
  23. Liu T, Zhu L, Wang L. 2022. A narrative review of the pharmacology of ginsenoside compound K. Ann. Transl. Med. 10:234.
  24. Nakhjavani M, Hardingham JE, Palethorpe HM, Tomita Y, Smith E, Price TJ, Townsend AR. 2019. Ginsenoside Rg3: potential molecular targets and therapeutic indication in metastatic breast cancer. Medicines (Basel) 6:17.
  25. Park S, Lee HJ, Jeong SJ, Song HS, Kim M, Lee HJ, Lee EO, Kim DH, Ahn KS, Kim SH. 2011. Inhibition of JAK1/STAT3 signaling mediates compound K-induced apoptosis in human multiple myeloma U266 cells. Food Chem. Toxicol. 49:1367-1372. https://doi.org/10.1016/j.fct.2011.03.021
  26. Ratan ZA, Haidere MF, Hong YH, Park SH, Lee JO, Lee J, Cho JY. 2021. Pharmacological potential of ginseng and its major component ginsenosides. J. Ginseng Res. 45:199-210. https://doi.org/10.1016/j.jgr.2020.02.004
  27. Shin HY, Chu SH, Lee H, Lee JW. 2011. mTOR inhibitor as a potential drug of age-related disease. Korean J. Clin. Geriatr. 12:149-159.
  28. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71:209-249. https://doi.org/10.3322/caac.21660
  29. Sung ND, Kim MR, Ha JH, Kwon BM, Chung HW, Ahn BT, Ryu SY. 2000. Searching of cyclin-dependent kinase 4/Cyclin D1 enzyme inhibition materials from the native plants. J. Korean. Soc. Agric. Chem. Biotechnol. 43:174-178.
  30. Tarantino P, Corti C, Schmid P, Cortes J, Mittendorf EA, Rugo H, Tolaney SM, Bianchini G, Andre F, Curigliano G. 2022. Immunotherapy for early triple negative breast cancer: research agenda for the next decade. NPJ Breast Cancer 8:23.
  31. Ueng SH, Chen SC, Chang YS, Hsueh S, Lin YC, Chien HP, Lo YF, Shen SC, Hsueh C. 2012. Phosphorylated mTOR expression correlates with poor outcome in early-stage triple negative breast carcinomas. Int. J. Clin. Exp. Pathol. 5:806-813.
  32. Wang H, Jiang D, Liu J, Ye S, Xiao S, Wang W, Sun Z, Xie Y, Wang J. 2013. Compound K induces apoptosis of bladder cancer T24 cells via reactive oxygen species-mediated p38 MAPK pathway. Cancer Biother. Radiopharm. 28:607-614. https://doi.org/10.1089/cbr.2012.1468
  33. Wazir U, Newbold RF, Jiang WG, Sharma AK, Mokbel K. 2013. Prognostic and therapeutic implications of mTORC1 and Rictor expression in human breast cancer. Oncol. Rep. 29:1969-1974. https://doi.org/10.3892/or.2013.2346
  34. Wu H, Guo H, Liu H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L. 2020. Copper sulfate-induced endoplasmic reticulum stress promotes hepatic apoptosis by activating CHOP, JNK and caspase-12 signaling pathways. Ecotoxicol. Environ. Saf. 191:110236.
  35. Xu K, Liu P, Wei W. 2014. mTOR signaling in tumorigenesis. Biochim. Biophys. Acta 1846:638-654. https://doi.org/10.1016/j.bbcan.2014.10.007
  36. Yang Y, Liu X, Li S, Chen Y, Zhao Y, Wei Y, Qiu Y, Liu Y, Zhou Z, Han J, Wu G, Ding Q. 2020. Genome-scale CRISPR screening for potential targets of ginsenoside compound K. Cell Death Dis. 11:39.
  37. Yao H, Wan JY, Zeng J, Huang WH, Sava-Segal C, Li L, Niu X, Wang Q, Wang CZ, Yuan CS. 2018. Effects of compound K, an enteric microbiome metabolite of ginseng, in the treatment of inflammation associated colon cancer. Oncol. Lett. 15:8339-8348. https://doi.org/10.3892/ol.2018.8414
  38. Zhang X, Zhang S, Sun Q, Jiao W, Yan Y, Zhang X. 2018. Compound K induces endoplasmic reticulum stress and apoptosis in human liver cancer cells by regulating STAT3. Molecules 23:1482.